6598.TW Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 01:30):

Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex diagnostic testing products for the In-Vitro diagnostics market...

Stats
Today's Volume	104 470
Average Volume	55 606.00
Market Cap	1.60B
EPS	TWD0 ( 2024-03-15 )
Next earnings date	( TWD0 ) 2024-05-10
Last Dividend	TWD0 ( N/A )
Next Dividend	TWD0 ( N/A )
P/E	-9.73
ATR14	TWD0.0250 (0.13%)

Applied BioCode Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Applied BioCode Correlation - Currency/Commodity

0.59
( weak )

0.58
( weak )

0.00
( neutral )

0.51
( weak )

-0.60
( weak negative )

-0.54
( weak negative )

Applied BioCode Financials

Annual	2023
Revenue:	TWD395.17M
Gross Profit:	TWD223.53M (56.57 %)
EPS:	TWD-2.01

FY	2023
Revenue:	TWD395.17M
Gross Profit:	TWD223.53M (56.57 %)
EPS:	TWD-2.01

FY	2022
Revenue:	TWD390.30M
Gross Profit:	TWD234.17M (60.00 %)
EPS:	TWD-2.26

FY	2021
Revenue:	TWD319.96M
Gross Profit:	TWD189.37M (59.18 %)
EPS:	TWD-2.02

Financial Reports:

No articles found.

Applied BioCode

Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex diagnostic testing products for the In-Vitro diagnostics market. The company's products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testing; and the BioCode 2500 analyzer, a system that reads barcoded magnetic beads (BMB) and displays the barcode and fluorescence intensity for each BMB. In addition, It develops assays, such as BioCode SARS-CoV-2 Assay, a high volume automated nucleic acid multiplex assay for the detection of SARS-CoV-2 nucleic acid in nasopharyngeal swabs; BioCode Respiratory Pathogen Panels, which simultaneously detects and differentiates the presence of 17 respiratory pathogens in nasopharyngeal swabs; BioCode gastrointestinal (GI) pathogen panels for common GI pathogens, including viruses, bacteria, and parasites that cause infectious diarrhea; and MDx assays pipeline for various molecular tests. Further, the company offers fungal pathogen analyte specific reagents; human cytokine/chemokine multiplex kits to identify relevant biomarkers; mouse premixed multiplex kits and custom panels for enhancing flexibility in experimental design allowing the user to pick and choose their own analytes panel; and rat, monkey, canine, and non-human primate cytokine/chemokine multiplex kits. Additionally, the company provides BMB, calibration beads, and coupling kits for various bioassay applications; ELISA, a tool for the quantitative measurement of drug/protein/antibody levels in biological samples comprising cell lysate or serum; and various assay development services. Applied BioCode Corporation is based in Santa Fe Springs, California.